Data as of May 20
| +0.11 / +3.40%|
The 4 analysts offering 12-month price forecasts for Apricus Biosciences Inc have a median target of 5.25, with a high estimate of 8.00 and a low estimate of 3.75. The median estimate represents a +56.72% increase from the last price of 3.35.
The current consensus among 4 polled investment analysts is to Buy stock in Apricus Biosciences Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.